News

Meet us at DCAT Week

Meet us at DCAT Week, the premier business development event for companies engaged in pharmaceutical development and manufacturing. Contact us today to schedule a meeting! Noramco is a global leader in controlled substance APIs for the pharmaceutical industry, focusing on ...
Read More

Noramco Cannabinoids Business to Become Purisys

Two Organizations Will Build on Strengths to Address Differentiated End-Use Markets Wilmington, DE 19 September 2019 – Noramco announced today that its industry-leading cannabinoids business will become a separate company – Purisys, LLC. Purisys will focus exclusively on acting as ...
Read More

Noramco at CPhI 2019

Visit us at stand 40F41 at CPhI Worldwide in Frankfurt, Germany to find out more about the latest products and developments from Noramco. To find out more, go to: https://www.cphi.com/europe/ ...
Read More

Noramco at AAPS 2019

Visit us at AAPS, booth #721, to find out more about the latest products and developments from Noramco ...
Read More

Noramco at iCDP

Noramco is a proud partner of the International Cannabinoid Derived Pharmaceuticals Summit (iCDP), taking place on September 10-12, 2019 in Boston, MA. Joshua Hoerner will be presenting on Wednesday, September 11, 2019, at 11:45 am. The topic will be on ...
Read More

Say Hello to Amber Burch

Amber Burch came to Noramco from a small company environment and thoroughly enjoys working at Noramco, “a very dynamic place to work with a lot of growth”. Working at Noramco and understanding the ins and outs of pharmaceutical manufacturing has ...
Read More

Say Hello to Gregory Moore

Gregory Moore joined Noramco as a temp one month after retiring from the U.S. Air Force in August 2014. Within a year, he was hired to a permanent position. Coming to Noramco with no chemical operations experience, Gregory recalls that ...
Read More

Noramco Presents Comments and Answers Questions at FDA Hearing on Cannabidiol

Support for emerging market includes positions on rigorous science, consumer safety and monitoring of intermediates and end-products Wilmington, DE – Noramco, a leading manufacturer of cannabidiol (CBD) and related compounds presented testimony and answered questions at the Food and Drug ...
Read More

Noramco and Willow Biosciences Announce Joint Development of Biosynthesis Platform for Cannabidiol

New activity will add options and potential for cost savings to Noramco’s robust CBD platform in support of emerging markets Wilmington, DE – Noramco, a leading manufacturer of cannabinoids, and Willow Biosciences Inc. (“Willow”), a leading developer of biosynthetic production ...
Read More

Say Hello to Elizabeth Abercrombie

Recently graduated, Elizabeth Abercrombie joined the company in June 2017 because she saw it as “an exciting and diverse place to work. I knew immediately I would be exposed to so many aspects of the industry that I would not ...
Read More

Events

CPhi 2019
November 5 – 7, 2019
Frankfurt, Germany

AAPS 2019
November 3 – 6, 2019
San Antonio, TX

iCDP Summit
September 10 – 12, 2019
Boston, MA